Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02541032 : PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Patient is at least 18 years of age with no upper age limit

2. Patient is able to consent, follow an outpatient protocol, and is available by
telephone

3. Non-severely disabling initial stroke (modified Rankin score ? 3) or TIA in the past
90 days

4. Evaluable for periodontal examination and treatment (? 5 teeth) and able to sustain a
dental examination

5. Contain ? 2 interproximal sites with ? 4 mm of clinical attachment loss (CAL)
(initial periodontitis as defined by the Centers for Disease Control (CDC) Working
Group on Surveillance Systems for Periodontal Infections - see below)

Exclusion Criteria:

1. Stroke due to intracranial hemorrhage, dissection, veno-occlusive disease, drugs,
trauma, or vasculitis

2. Previous neurological impairment that would make detection of a subsequent event
difficult

3. Co-morbid conditions that may limit survival to less than one year

4. Brain CT or MRI which shows a lesion other than stroke as the cause of the syndrome

5. History of medical conditions requiring antibiotic prophylaxis prior to dental exam
(artificial cardiac valves, previous inflammation of the heart or valves, complex
heart conditions or other heart malformations since birth, surgically constructed
systemic pulmonary shunts, valvular dysfunctions, prolapse, hypertrophic
cardiomyopathy, first two years of joint replacement, previous infections from
artificial joint, any chronic or radiation-induced condition leading to
immunosuppression or hemophilia)

6. Patients on oral anticoagulant therapy with a Prothrombin Time International
Normalized Ratio (PT-INR) greater than 3.5 (may be corrected and enrolled).

7. Pregnancy confirmed by urine pregnancy test in women of child-bearing potential (? 55
years age)

8. Known allergy or hypersensitivity to local anesthesia or minocycline that cannot be
medically managed

9. Participation in another randomized clinical trial.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02541032      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740